Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples